FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction FDA Evaluates Peptides for Section 503A Compounding List Lance Liberti, MBA, BCPA posted on the topic LinkedIn FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies